Home › Funds › Lynx1 Capital Management LP › FHTX

Lynx1 Capital Management LP position in FHTX

FOGHORN THERAPEUTICS INC · Health Care

Lynx1 Capital Management LP reported holding 61,588 shares of FHTX (FOGHORN THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$220K, representing 0.03% of its reported portfolio and ranking #25 among its reported holdings. Lynx1 Capital Management LP has disclosed FHTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)61.59K sh
Reported value held$219.87K
Portfolio Weight0.03%
First reportedQ2 2026
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's FHTX position evolved

Lynx1 Capital Management LP first disclosed a stake in FHTX in Q2 2026 at 61,588 shares (US$301K). Across 2 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 61,588 shares valued at US$220K.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 61.59K $300.55K New
Q3 2026 61.59K $219.87K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About FHTX and 13F data

FHTX (FOGHORN THERAPEUTICS INC) is a Health Care company. 29 other funds we track also report a position in FHTX — the largest reported positions include Flagship Pioneering, LLC (US$45.2M), BVF INC/IL (US$20.9M), Euclidean Capital LLC (US$5.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding FHTX

All FHTX fund holders →

FAQ

How long has Lynx1 Capital Management LP held FHTX?

Lynx1 Capital Management LP has disclosed FHTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Lynx1 Capital Management LP's current position in FHTX?

As of Q3 2026, Lynx1 Capital Management LP holds 61.59K shares of FHTX (FOGHORN THERAPEUTICS INC), valued at $219.87K, representing 0.03% of its reported portfolio and ranking #25.

Has Lynx1 Capital Management LP been buying or selling FHTX?

In the latest 13F filing (Q3 2026), Lynx1 Capital Management LP held unchanged its position in FHTX.

Which other funds hold FHTX?

Other major institutional holders of FHTX include Flagship Pioneering, LLC, BVF INC/IL, Euclidean Capital LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.